CDK4 and neoplasm: The observed anti-tumor activities of celastrol and its derivatives both in vitro and in vivo promoted degradation and decreased phosphorylation of protein kinases that are known to be highly activated in HCC cells, such as Raf family proteins, AKT, MEK1/2, CDK4, and EGFR.